{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:08:43Z","timestamp":1775621323517,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jiph.2025.102992","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:57:27Z","timestamp":1760072247000},"page":"102992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nationwide evaluation of hepatitis medication prescription patterns and costs in hepatitis B and C care"],"prefix":"10.1016","volume":"18","author":[{"given":"Zahra","family":"Aminzade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Mehrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-748X","authenticated-orcid":false,"given":"Leila","family":"Ghamkhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khavari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Effatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Mehdi","family":"Nasehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajabali","family":"Daroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Arab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Shahali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Karami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.102992_bib1","series-title":"StatPearls Publishing Copyright \u00a9 2024","article-title":"Viral hepatitis. Statpearls. Treasure island (FL)","author":"Mehta","year":"2024"},{"key":"10.1016\/j.jiph.2025.102992_bib2","unstructured":"Saeed U., Waheed Y., Ashraf M. Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology. (2222-1808 (Print))."},{"key":"10.1016\/j.jiph.2025.102992_bib3","doi-asserted-by":"crossref","first-page":"q833","DOI":"10.1136\/bmj.q833","article-title":"Hepatitis: WHO publishes warning over rise in global deaths","volume":"385","author":"Iacobucci","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2025.102992_bib4","unstructured":"Organization W.H. 2024. Global hepatitis report 2024: action for access in low-and middle-income countries: World Health Organization.."},{"issue":"7","key":"10.1016\/j.jiph.2025.102992_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.26719\/emhj.19.077","article-title":"Estimating the incidence rate of hepatitis B and C in east Azerbaijan, Islamic Republic of Iran","volume":"26","author":"Somi","year":"2020","journal-title":"East Mediterr Health J"},{"issue":"3","key":"10.1016\/j.jiph.2025.102992_bib6","article-title":"Hepatitis c virus infection in Iran: a review of current prevalence and preventive strategies from a developing country","volume":"4","author":"Tantuoyir","year":"2024","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102992_bib7","article-title":"Impact of the COVID-19 pandemic on hepatitis b and c elimination: an EASL survey","volume":"4","author":"Kondili","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jiph.2025.102992_bib8","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","author":"Organization","year":"2022"},{"key":"10.1016\/j.jiph.2025.102992_bib9","unstructured":"Organization W.H. 2024. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection: World Health Organization.."},{"issue":"6","key":"10.1016\/j.jiph.2025.102992_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2025.102992_bib11","unstructured":"Zoratti M., Organization W.H.Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection: web annex 3.1: adult hepatitis C virus treatment systematic review2018."},{"key":"10.1016\/j.jiph.2025.102992_bib12","series-title":"Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics","author":"Organization","year":"2022"},{"issue":"6","key":"10.1016\/j.jiph.2025.102992_bib13","first-page":"795","article-title":"Factors influencing prescribing decisions of physicians: a review","volume":"28","author":"Davari","year":"2018","journal-title":"Ethiop J Health Sci"},{"issue":"5","key":"10.1016\/j.jiph.2025.102992_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055091","article-title":"Factors influencing the prescription pattern of essential medicines from the perspectives of general practitioners and patients: a qualitative study in China","volume":"12","author":"Chen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiph.2025.102992_bib15","series-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis","author":"Organization","year":"2016"},{"key":"10.1016\/j.jiph.2025.102992_bib16","unstructured":"Polaris Observatory. Center for Disease Analysis. [Internet]. Available from: \u3008http:\/\/cdafound.org\/polaris\/\u3009."},{"key":"10.1016\/j.jiph.2025.102992_bib17","unstructured":"World Health A. Draft global health sector strategies: viral hepatitis, 2016\u20132021: report by the Secretariat. Geneva: World Health Organization; 2016."},{"key":"10.1016\/j.jiph.2025.102992_bib18","author":"Organization","year":"2021","journal-title":"Anat Ther Chem (ATC) Classif"},{"key":"10.1016\/j.jiph.2025.102992_bib19","unstructured":"Generalized ESD Test for Outliers [Available from: \u3008https:\/\/www.itl.nist.gov\/div898\/handbook\/eda\/section3\/eda35h3.htm\u3009."},{"key":"10.1016\/j.jiph.2025.102992_bib20","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796-829.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"10.1016\/j.jiph.2025.102992_bib21","unstructured":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879-907."},{"issue":"1","key":"10.1016\/j.jiph.2025.102992_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41598-017-18296-9","article-title":"The epidemiology of hepatitis C virus in Iran: systematic review and meta-analyses","volume":"8","author":"Mahmud","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.102992_bib23","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.17601.3","article-title":"Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts","volume":"7","author":"Brown","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jiph.2025.102992_bib24","article-title":"Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China","volume":"10","author":"Liu","year":"2022","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.jiph.2025.102992_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","article-title":"WHO 2024 hepatitis B guidelines: an opportunity to transform care","volume":"9","author":"Easterbrook","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102992_bib26","first-page":"534","article-title":"Gaps in hepatitis B evaluation and treatment","volume":"18","author":"Coffin","year":"2022","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jiph.2025.102992_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81070","article-title":"The forgotten people: hepatitis B virus (HBV) infection as a priority for the inclusion health agenda","volume":"12","author":"Martyn","year":"2023","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.jiph.2025.102992_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jvh.13685","article-title":"Closing the hepatitis c treatment gap: United States strategies to improve retention in care","volume":"29","author":"Jones","year":"2022","journal-title":"J Viral Hepat"},{"issue":"9","key":"10.1016\/j.jiph.2025.102992_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.50","article-title":"Hepatitis C treatment and barriers to eradication","volume":"7","author":"Konerman","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"10.1016\/j.jiph.2025.102992_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cld.2019.04.008","article-title":"WHO guidelines for prevention, care and treatment of individuals infected with HBV: a US perspective","volume":"23","author":"Vittal","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102992_bib31","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jiph.2025.102992_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijms.43079","article-title":"Direct-acting antiviral in the treatment of chronic hepatitis C: bonuses and challenges","volume":"17","author":"Zeng","year":"2020","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.jiph.2025.102992_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43066-022-00226-8","article-title":"The art of managing hepatitis C virus in special population groups: a paradigm shift","volume":"12","author":"Elbadry","year":"2022","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jiph.2025.102992_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00535-017-1427-x","article-title":"Treatment of hepatitis C in special populations","volume":"53","author":"Suda","year":"2018","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jiph.2025.102992_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jare.2014.11.004","article-title":"New era for management of chronic hepatitis C virus using direct antiviral agents: a review","volume":"6","author":"Elbaz","year":"2015","journal-title":"J Adv Res"},{"issue":"11","key":"10.1016\/j.jiph.2025.102992_bib36","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1080\/03007995.2019.1643160","article-title":"Impact of pill burden on adherence to hepatitis C medication","volume":"35","author":"An","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.jiph.2025.102992_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gastha.2022.10.004","article-title":"It is time for a simplified approach to hepatitis B elimination","volume":"2","author":"Dieterich","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.jiph.2025.102992_bib38","first-page":"45","article-title":"Step by step: managing the complications of cirrhosis","volume":"13","author":"Perez","year":"2021","journal-title":"Hepat Med"},{"issue":"7","key":"10.1016\/j.jiph.2025.102992_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102992_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcm121","article-title":"Fluid retention in cirrhosis: pathophysiology and management","volume":"101","author":"Kashani","year":"2008","journal-title":"QJM Int J Med"},{"issue":"2","key":"10.1016\/j.jiph.2025.102992_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/13596535211067605","article-title":"Adefovir for lamivudine-resistant hepatitis B","volume":"27","author":"Roediger","year":"2022","journal-title":"Antivir Ther"},{"issue":"5","key":"10.1016\/j.jiph.2025.102992_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000360399","article-title":"Adefovir and lamivudine combination therapy in patients with Entecavir-Resistant chronic hepatitis B: antiviral responses and evolution of mutations","volume":"57","author":"Yim","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.jiph.2025.102992_bib43","first-page":"21","article-title":"Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life","volume":"8","author":"Pol","year":"2016","journal-title":"Hepat Med"},{"key":"10.1016\/j.jiph.2025.102992_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9616234","article-title":"Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of Egyptian patients: an experiment the size of Egyptian village","volume":"2018","author":"Ahmed","year":"2018","journal-title":"Int J Hepatol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102992_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2017.11.034","article-title":"Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience","volume":"68","author":"Elsharkawy","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102992_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/fampra\/cmac070","article-title":"Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the rijnmond primary care database","volume":"40","author":"Brakenhoff","year":"2023","journal-title":"Fam Pract"},{"issue":"5","key":"10.1016\/j.jiph.2025.102992_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1499-3872(14)60313-1","article-title":"Role of general practitioners in prevention and treatment of hepatitis B in China","volume":"13","author":"Ren","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"10.1016\/j.jiph.2025.102992_bib48","first-page":"51","article-title":"The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries","volume":"57","author":"Bechini","year":"2016","journal-title":"J Prev Med Hyg"},{"issue":"4","key":"10.1016\/j.jiph.2025.102992_bib49","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.15(4)2015.25854","article-title":"Economic burden of hepatitis B virus-related diseases: evidence from Iran","volume":"15","author":"Keshavarz","year":"2015","journal-title":"Hepat Mon"},{"issue":"10","key":"10.1016\/j.jiph.2025.102992_bib50","first-page":"1575","article-title":"The estimation of economic burden of hepatitis C virus infection in Iran","volume":"47","author":"Mohammadzadeh","year":"2018","journal-title":"Iran J Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2025.102992_bib51","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.40541","article-title":"The estimation of economic burden of hepatitis B virus infection in Iran","volume":"17","author":"Mohammadzadeh","year":"2017","journal-title":"Hepat Mon"},{"issue":"7","key":"10.1016\/j.jiph.2025.102992_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/OLQ.0000000000001632","article-title":"Cost-Effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections","volume":"49","author":"Hutton","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102992_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy353","article-title":"Cost-effectiveness of hepatitis B virus infection screening and treatment or vaccination in 6 High-risk populations in the United States","volume":"6","author":"Chahal","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.jiph.2025.102992_bib54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jvh.13843","article-title":"Cost-effectiveness of treating all hepatitis B-positive individuals in the United States","volume":"30","author":"Razavi-Shearer","year":"2023","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.jiph.2025.102992_bib55","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jval.2020.06.015","article-title":"Cost-Effectiveness of testing and treatment for hepatitis B virus and hepatitis C virus infections: an analysis by scenarios, regions, and income","volume":"23","author":"Tordrup","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.jiph.2025.102992_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112078","article-title":"Prescription patterns and the cost of antihyperglycemic drugs in patients with diabetes mellitus in Iran from 2014 to 2019","volume":"223","author":"Rezaee","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jiph.2025.102992_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058757","article-title":"Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study","volume":"12","author":"Tasavon Gholamhoseini","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiph.2025.102992_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2022.102307","article-title":"Assigning diagnosis codes using medication history","volume":"128","author":"Hansen","year":"2022","journal-title":"Artif Intell Med"},{"issue":"3","key":"10.1016\/j.jiph.2025.102992_bib59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records","volume":"33","author":"Schultz","year":"2013","journal-title":"Chronic Dis Inj Can"},{"issue":"2","key":"10.1016\/j.jiph.2025.102992_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhepr.2019.04.002","article-title":"Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO member state responses 2017","volume":"1","author":"Smith","year":"2019","journal-title":"JHEP Rep"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:27:42Z","timestamp":1762666062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1876034125003417"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102992","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nationwide evaluation of hepatitis medication prescription patterns and costs in hepatitis B and C care","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102992"}}